Fuel crisis of aging neurons could explain Parkinson’s disease
Original story from Weill Cornell Medicine (NY, USA).
Dopamine neurons in a part of the brain called the midbrain may, with aging, be increasingly susceptible to a vicious spiral of decline driven by fuel shortages, according to a study led by Weill Cornell Medicine (NY, USA) investigators. The findings offer a potential explanation for the degeneration of this neuron population in Parkinson’s disease.
In a recent study, scientists examined how midbrain dopamine neurons, which have numerous output branches, handle their high energy requirements. They showed that these neurons under normal conditions create a fuel reserve in the form of clusters of glucose molecules called glycogen. This allows the neurons to keep working for a surprisingly long time even when their usual supply of glucose from the blood is interrupted. However, the researchers also discovered that the neurons regulate their glycogen storage in a way that can leave them highly vulnerable to glucose shortages, especially as their functions begin to decline with aging.
“This vulnerability may explain the deaths of these midbrain neurons in Parkinson’s and is consistent with the idea that energy insufficiency is a common failure mode in neurological disorders,” explained study senior author Timothy Ryan, the Tri-Institutional Professor of Biochemistry and Biophysics and a professor of biochemistry in anesthesiology at Weill Cornell Medicine.
Midbrain dopamine neurons – specifically in a region called the substantia nigra pars compacta – help regulate voluntary muscle movements as well as learning and motivation. Their degeneration in Parkinson’s accounts for the classic muscle rigidity and other ‘motor signs’ of the disease. Why most of these neurons degenerate in Parkinson’s is still not clear, though there is evidence that their functions begin to decline and their numbers decrease even with ordinary aging.
Identifying key hallmarks of the aging brain
How protein dysfunction, a key driver of aging, develops in vertebrate brain cells is revealed by a study of killifish.
In the new study, Ryan and his team, including first author Camila Pulido, a research associate in biochemistry and biophysics, observed that rat midbrain dopamine neurons are remarkably resilient to interruptions in the usually continuous supply of glucose. Suspecting that these neurons create their own glycogen fuel reserve, as some muscle cells do, they confirmed this using a special glycogen-detecting antibody – the first direct demonstration that neurons make glycogen.
The team then discovered that these dopamine neurons regulate their synthesis of glycogen using dopamine-sensing receptors – known as D2 receptors – on their own output terminals. Thus, more dopamine output means more D2 receptor activity and more glycogen storage. But this unexpected form of regulation creates a potentially dangerous vulnerability, in which less dopamine output leads to less glycogen storage. As the team’s experiments showed, when the neurons had no more glycogen stores, they became hypersensitive to glucose deprivation, ceasing to function almost immediately.
The researchers hypothesize that some combination of aging, environmental exposures and genetic risk factors can cause declines in these neurons’ dopamine outputs that result in reduced fuel resilience, worsening dysfunction and ultimately degeneration. They note that many of the known gene mutations linked to Parkinson’s cause impairments of cellular fuel supply and thus would increase the tendency for these neurons to enter this destructive spiral.
“Also consistent with our hypothesis is the fact that some antipsychotic medications, which reduce the activity of D2 receptors, presumably reducing glycogen storage in these neurons, can cause Parkinson’s-like movement dysfunctions as side effects,” Ryan commented.
If this hypothesis is correct, then interventions to improve midbrain dopamine neurons’ resilience to glucose shortages might be able to prevent Parkinson’s or arrest its progress once it starts.
The researchers now plan to follow up with studies of glycogen storage in other types of neurons.
“We want to look first at how different dopamine neuron populations across the nervous system differ in their storage of glycogen,” Pulido added.
This article has been republished from the following materials. Material may have been edited for length and house style. For further information, please contact the cited source. Our press release publishing policy can be accessed here.